参考文献
2020-10-21
1: Karachaliou N, Chaib I, Cardona AF, Berenguer J, Bracht JWP, Yang J, Cai X,
Wang Z, Hu C, Drozdowskyj A, Servat CC, Servat JC, Ito M, Attili I, Aldeguer E,
Capitan AG, Rodriguez J, Rojas L, Viteri S, Molina-Vila MA, Ou SI, Okada M, Mok
TS, Bivona TG, Ono M, Cui J, Cajal SRY, Cao P, Rosell R. Common Co-activation of
AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With
Poor Prognosis. EBioMedicine. 2018 Feb 5. pii: S2352-3964(18)30050-1. doi:
10.1016/j.ebiom.2018.02.001. [Epub ahead of print] PubMed PMID: 29433983.
Wang Z, Hu C, Drozdowskyj A, Servat CC, Servat JC, Ito M, Attili I, Aldeguer E,
Capitan AG, Rodriguez J, Rojas L, Viteri S, Molina-Vila MA, Ou SI, Okada M, Mok
TS, Bivona TG, Ono M, Cui J, Cajal SRY, Cao P, Rosell R. Common Co-activation of
AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With
Poor Prognosis. EBioMedicine. 2018 Feb 5. pii: S2352-3964(18)30050-1. doi:
10.1016/j.ebiom.2018.02.001. [Epub ahead of print] PubMed PMID: 29433983.